Lumacaftor - Qanatpharma
Alternative Names: QP-01Latest Information Update: 07 Nov 2023
At a glance
- Originator Qanatpharma
- Class Amides; Antihaemorrhagics; Benzodioxoles; Benzoic acids; Cyclopropanes; Fluorinated hydrocarbons; Heart failure therapies; Pyridines; Small molecules
- Mechanism of Action Cystic fibrosis transmembrane conductance regulator stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Heart failure; Subarachnoid haemorrhage